Skip to main content
Clinical Trials/NCT03506685
NCT03506685
Withdrawn
Not Applicable

The Effectiveness of Dry Needling and Soft Tissue Mobilization in the Management of Pain Post Anterior Cruciate Ligament (ACL) Reconstruction: A Randomized Controlled Trial

Keller Army Community Hospital1 site in 1 country40 target enrollmentJune 1, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pain and Anterior Cruciate Ligament Reconstruction
Sponsor
Keller Army Community Hospital
Enrollment
40
Locations
1
Primary Endpoint
Numerical pain rating scale
Status
Withdrawn
Last Updated
7 months ago

Overview

Brief Summary

The purpose of this study is to determine if dry needling (DN) and soft tissue mobilization (STM) is superior to standard treatment protocol for affecting pain, pain medication usage and measurements of range of motion (ROM) after ACL reconstruction surgery compared to a standard treatment protocol. Measurements of pain, pain medication usage, lower extremity functional scale (LEFS) and ROM will be taken day 2 post op and 1 week, 2 weeks, 3 weeks, and 4 weeks post op. It is hypothesized that the inclusion of DN and STM will acutely decrease the demand for pain medication and improve objective measurements when compared to a standard treatment protocol. Findings will potentially lead to insights as to the benefit of applying these interventions to help decrease the demand for pain medication post-surgery.

Registry
clinicaltrials.gov
Start Date
June 1, 2018
End Date
June 1, 2019
Last Updated
7 months ago
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jamie Morris

principal Investigator

Keller Army Community Hospital

Eligibility Criteria

Inclusion Criteria

  • Age 18-40 Department of Defense( DOD) beneficiaries (17 if Cadet)
  • Scheduled for ACL Reconstruction Surgery

Exclusion Criteria

  • Self-Reported Pregnancy
  • History of blood borne pathogens/infectious disease/active infection/metal allergy
  • Bleeding disorders or currently taking anti-coagulant medications
  • Participants who are not fluent in English

Outcomes

Primary Outcomes

Numerical pain rating scale

Time Frame: change from baseline, 2 days post-op, 1 week, 2 week, 3 week, 4 week

validated outcome measure for pain ranging from 0-10

Secondary Outcomes

  • Lower extremity functional scale(change from baseline, 2 days post-op, 1 week, 2 week, 3 week, 4 week)
  • Global rate of change(change from baseline, 2 days post-op, 1 week, 2 week, 3 week, 4 week)
  • knee range of motion(change from baseline, 2 days post-op, 1 week, 2 week, 3 week, 4 week)

Study Sites (1)

Loading locations...

Similar Trials